Jonathan Leff
Direttore/Membro del Consiglio presso Avalyn Pharma, Inc.
Posizioni attive di Jonathan Leff
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | 01/04/2017 | - |
| Independent Dir/Board Member | 01/04/2017 | - | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investitore di Private Equity | 17/03/2020 | - |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Direttore/Membro del Consiglio | 01/02/2022 | - |
Storia della carriera di Jonathan Leff
Precedenti posizioni note di Jonathan Leff
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AEROVATE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2020 | 01/04/2021 |
| ASCENDIS PHARMA A/S | Direttore Tecnico/Scientifico/R&S | 26/02/2016 | 01/10/2019 |
| INTERMUNE INC | Direttore Tecnico/Scientifico/R&S | 31/07/2012 | 31/03/2015 |
| HUMANIGEN, INC. | Vendite & Marketing | 01/02/2011 | 01/02/2012 |
| HUMANIGEN, INC. | Corporate Officer/Principal | 01/01/2011 | 01/02/2012 |
| HALOZYME THERAPEUTICS, INC. | Vendite & Marketing | 01/07/2009 | 01/10/2010 |
| ░░░░░ ░░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Jonathan Leff
| University of Pennsylvania | Undergraduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 13 |
| Danimarca | 2 |
| Paesi Bassi | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
Settori
| Health Technology | 11 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| AEROVATE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Leff
- Esperienza
